These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8579908)

  • 1. FDA Guidelines and animal models for osteoporosis.
    Thompson DD; Simmons HA; Pirie CM; Ke HZ
    Bone; 1995 Oct; 17(4 Suppl):125S-133S. PubMed ID: 8579908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT; Yuan D; Power RA; Wronski TJ
    J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy.
    Boyce RW; Wronski TJ; Ebert DC; Stevens ML; Paddock CL; Youngs TA; Gundersen HJ
    Bone; 1995 Feb; 16(2):209-13. PubMed ID: 7756049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
    Erben RG; Bromm S; Stangassinger M
    Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
    Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
    Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats.
    Zhang L; Endo N; Yamamoto N; Tanizawa T; Takahashi HE
    Tohoku J Exp Med; 1998 Oct; 186(2):131-41. PubMed ID: 10223616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of femoral neck osteopenia in ovariectomized rats.
    Li M; Shen Y; Wronski TJ
    Bone; 1997 Jan; 20(1):55-61. PubMed ID: 8988348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.
    Shen V; Dempster DW; Mellish RW; Birchman R; Horbert W; Lindsay R
    Calcif Tissue Int; 1992 Mar; 50(3):214-20. PubMed ID: 1617495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
    Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.
    Erben RG; Weiser H; Sinowatz F; Rambeck WA; Zucker H
    Calcif Tissue Int; 1992 Mar; 50(3):228-36. PubMed ID: 1617497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In search of an animal model for postmenopausal diseases.
    Thorndike EA; Turner AS
    Front Biosci; 1998 Apr; 3():c17-26. PubMed ID: 9545440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats.
    Li M; Shen Y; Burton KW; DeLuca PP; Mehta RC; Baumann BD; Wronski TJ
    Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats.
    Shen V; Birchman R; Xu R; Lindsay R; Dempster DW
    Bone; 1995 Jan; 16(1):149-56. PubMed ID: 7742074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.